Package 70518-0541-2

{"route": ["ORAL"], "spl_id": "47f7d1d0-101a-490e-e063-6394a90af266", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["1ecd2332-4c60-46c1-a175-774926ffc6c6"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-0541-1)", "package_ndc": "70518-0541-1", "marketing_start_date": "20250929"}, {"sample": false, "description": "5 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-0541-2)", "package_ndc": "70518-0541-2", "marketing_start_date": "20250929"}, {"sample": false, "description": "20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-0541-3)", "package_ndc": "70518-0541-3", "marketing_start_date": "20251003"}, {"sample": false, "description": "4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-0541-4)", "package_ndc": "70518-0541-4", "marketing_start_date": "20251030"}, {"sample": false, "description": "5 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-0541-5)", "package_ndc": "70518-0541-5", "marketing_start_date": "20251030"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "70518-0541_47f7d1d0-101a-490e-e063-6394a90af266", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70518-0541", "generic_name": "valacyclovir hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1 g/1"}], "application_number": "ANDA078518", "marketing_category": "ANDA", "marketing_start_date": "20170515", "listing_expiration_date": "20271231"}